For the first time, the Russian influenza vaccine, whose final stages of production are carried out at the MECHNIKOV Latin American Biotechnology Institute in Nicaragua, is used by the Ministry of Health of this country as part of the vaccination of people. The flu prevention campaign is taking place in Nicaragua from August 5 to
Tagged under: , ,
The current influenza strain antigen for the 2019-2020 vaccine season produced by FSUE SPbSRIVS FMBA of Russia promptly for the WHO system (GISRS) was used by the key laboratory (NIBSC) for manufacturing the standard antigen and received catalog number 19/154. This indicates a high level of quality of SPbSRIVS products that meet not only the
Tagged under: , ,
Institute MECHNIKOV, created as part of the Russian and Nicaraguan project in Managua, began production of commercial batches of influenza vaccine. April 10. Managua. Institute MECHNIKOV has launched the production of a commercial vaccine batches in Managua (Nicaragua). The launch of the production lines was attended by the advisor for investments of the Government of

The Flu: Stop the Spread

During the vaccination campaign in the Russian Federation, employees of the largest Russian manufacturer of influenza vaccines for adults, St. Petersburg Scientific Research Institute of Vaccines and Serums under Federal Medical Biological Agency of Russia were the first to have the opportunity to get vaccinated for more visit this site right here with a new influenza
Tagged under: ,

Updating knowledge with new impressions

Fifty foreign students from the Saint Petersburg State Chemical Pharmaceutical Academy became familiar with the modern biotechnology of the St. Petersburg Scientific Research Institute of Vaccines and Serums and Biopharmaceutical Plant under Federal Medical Biological Agency of Russia. Our Institute is cooperating successfully with the Saint Petersburg State Chemical Pharmaceutical Academy for several years. On a permanent basis,
Tagged under:
Sep. 6 – 15, under the patronage of President Bashar al-Assad, the 60th edition of Damascus International Fair was held. Among other participants, the Russian delegation was represented by the director of St. Petersburg Scientific Research Institute of Vaccines and Serums Victor Trukhin and the director’s advisor Sergey Arakelov. During the exhibition, Vladimir Uiba, the director of
Tagged under: , ,
In June 2018, as part of the strengthening of potential export, the St. Petersburg Scientific Research Institute of Vaccines and Serums has successfully passed the certification audit for compliance with antigen production quality for influenza vaccines. Food and Drug Administration of the Islamic Republic of Iran issued the certificate in August of this year. It
Director of PAHO Doc. Carissa Etienne visited Institute of vaccines and serums in Saint Petersburg (SPbSRIVS) within the framework of cooperation between Pan American Health Organization and Federal Medico-Biological Agency of Russia (FMBA), which along with other institutions includes SPbSRIVS. Doctor Etienne arrived to Russia to be acquainted with the latest achievements of Russian public
20 million
St. Petersburg Research Institute of Vaccines and Serums will produce more than 20 million doses of preventive flu vaccines. This epidemiological season SPbSRIVS will produce and deliver to Nacimbio (National Immunobiological Company) 20 million doses of preventive flu vaccines following the National calendar of vaccination. “First 6 millions of doses had been already shipped to